Perspective Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
114.1M
on 2026-06-30, from 58.7M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3ASR of 2024-05-24. Not read yet. S-3ASR ↗
7 of its filings are not read yet.
Cash
10.2 quarters
$236.9M on 2026-06-30 ÷ $23.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-02-02 | Public offering incl. 6.60M pre-funded | 46,174,134 | $3.79 | $175.0M | 424B5 ↗ |